Features

As industry discourse continues to discuss how real world evidence can be transformative for the regulatory landscape, Jacqueline Corrigan-Curay...

Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may hold for changing the way we...

As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves...

What will be the key industry trends in 2018? Here at Pharmafile, we look ahead to what we expect could be some of the major trends that will...

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the...

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the time to...

“You don’t need that linear career path – making brave career decisions is actually really valued”.

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out to the...

We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, Deputy Director...

Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine holds...